Status:
COMPLETED
Comparative 2-D Tumor Analysis in Familial Gliomas
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Malignant Glioma
Eligibility:
All Genders
18+ years
Brief Summary
The treatment for patients with malignant brain tumors is disappointing. The disease is incurable and virtually all patients die from their disease. Despite the devastating nature of this illness whic...
Detailed Description
The investigators propose to study the genetic changes in patients with familial glioma as the first step in identifying the gene(s) that cause these tumors. With informed consent, DNAs from tumor and...
Eligibility Criteria
Inclusion
- Malignant glioma with a blood relative with history of malignant glioma
Exclusion
- Inability to give consent
- Above criteria not met
Key Trial Info
Start Date :
June 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00125710
Start Date
June 1 1998
Last Update
July 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2